Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value
$1.11B
Total Bought
$87.41M
Total Sold
$267.53M
Net Transaction
-$180.12M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
SOLID BIOSCIENCES INC7,911,6699,808,819+1,897,15044,62270,6236.37%+26,002
CENTESSA PHARMACEUTICALS0635,000+635,000025,2222.27%+25,222
ALKERMES PLC(ALKS)0610,000+610,000021,5701.95%+21,570
DISC MEDICINE INC(IRON)0141,234+141,23409,0310.81%+9,031
XILIO THERAPEUTICS INC(XLO)0664,021+664,02105,5840.50%+5,584
C4 THERAPEUTICS INC(CCCC)7,171,9107,171,910013,69818,8621.70%+5,164
CABALETTA BIO INC(CABA)9,677,1259,677,125021,19326,0312.35%+4,839
ATEA PHARMACEUTICALS INC(AVIR)2,485,6382,360,638-125,0008,87412,7001.15%+3,827
ANNEXON INC(ANNX)5,249,0695,212,674-36,39526,35028,8782.60%+2,528
X4 PHARMACEUTICALS INC(XFOR)7,967,4547,967,454031,87032,9062.97%+1,036
DIANTHUS THERAPEUTICS INC(DNTH)743,592362,470-381,12230,64330,4182.74%-225
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
99,99999,99902,3002,0040.18%-296
PHARVARIS N V
COM
2,802,0812,675,509-126,57277,75875,5836.82%-2,175
KYVERNA THERAPEUTICS INC(KYTX)3,110,0003,110,000029,23426,8392.42%-2,395
XILIO THERAPEUTICS INC(XLO)7,372,6860-7,372,6864,7200—-4,720
RAPID MICRO BIOSYSTEMS INC(RPID)8,434,5608,434,560024,46019,1461.73%-5,314
TANGO THERAPEUTICS INC(TNGX)653,4930-653,4935,7900—-5,790
MERSANA THERAPEUTICS INC346,5450-346,54510,0260—-10,026
SAVARA INC(SVRA)17,600,62117,600,6210106,13296,0998.67%-10,032
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
7,306,5667,306,5660256,314233,88321.09%-22,431
UPSTREAM BIO INC(UPB)1,329,544867,211-462,33336,0977,8050.70%-28,292
OLEMA PHARMACEUTICALS INC(OLMA)8,508,6417,473,238-1,035,403212,716111,42610.05%-101,290
HEARTFLOW INC(HTFL)12,448,15810,448,158-2,000,000362,864254,20422.93%-108,660
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q1 2026 | TickerTrail